This week, there are 9 drugs in the patent and exclusivity list. They are: - AFT PHARMACEUTICALS US INC's COMBOGESIC, containing active ingredient ACETAMINOPHEN; IBUPROFEN - ACADIA PHARMACEUTICALS INC's NUPLAZID, containing active ingredient PIMAVANSERIN TARTRATE - NOVARTIS PHARMACEUTICALS CORP's TASIGNA, containing active ingredient NILOTINIB HYDROCHLORIDE - SECURA BIO INC's COPIKTRA, containing active ingredient DUVELISIB - UCB INC's FINTEPLA, containing active ingredient FENFLURAMINE HYDROCHLORIDE - PFIZER INC's VIZIMPRO, containing active ingredient DACOMITINIB - HARROW EYE LLC's IHEEZO, containing active ingredient CHLOROPROCAINE HYDROCHLORIDE - JAZZ PHARMACEUTICALS RESEARCH UK LTD's EPIDIOLEX, containing active ingredient CANNABIDIOL - INSMED INC's ARIKAYCE KIT, containing active ingredient AMIKACIN SULFATE Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - PFIZER INC's VIZIMPRO, containing active ingredient DACOMITINIB - SUMITOMO PHARMA AMERICA INC's APTIOM, containing active ingredient ESLICARBAZEPINE ACETATE - ASTRAZENECA LP's SYMBICORT, containing active ingredient BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - NEURELIS INC's VALTOCO, containing active ingredient DIAZEPAM - NOVARTIS PHARMACEUTICAL CORP's TABRECTA, containing active ingredient CAPMATINIB HYDROCHLORIDE - ELI LILLY AND CO's RETEVMO, containing active ingredient SELPERCATINIB - BRISTOL MYERS SQUIBB CO's SPRYCEL, containing active ingredient DASATINIB - ASTRAZENECA PHARMACEUTICALS LP's BRILINTA, containing active ingredient TICAGRELOR - ELI LILLY AND CO's OLUMIANT, containing active ingredient BARICITINIB Read More